Infection Viral clinical trials at UC Health

• COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial

  Sorry, not currently recruiting here

  The purpose of this study is to evaluate the safety, dose-requirements, and exploratory efficacy of twice-daily subcutaneous enoxaparin as venous thromboembolism prophylaxis in children (birth to 18 years) hospitalized with signs and/or symptoms of SARS-CoV-2 infection (i.e., COVID-19).

  at UC Davis

Last updated: January 25, 2021